Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 308,468 |
|
|||||
| News | (1) | ||||||
| Day High | 279.26 | Low High |
|||||
| Day Low | 273.28 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Madrigal Pharmaceuticals Inc | MDGL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.32 | -0.12% | 276.40 | 23:00:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 276.88 | 273.28 | 279.26 | 276.01 | 276.72 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,093 | 308,468 | US$ 275.90 | US$ 85,105,414 | - | 119.7604 - 299.98 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:18:32 | 1 | US$ 276.40 | USD |
Madrigal Pharmaceuticals (MDGL) Options Flow Summary
Madrigal Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.49B | 19.90M | - | 0 | -373.63M | -18.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Madrigal Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MDGL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 254.43 | 295.50 | 252.665 | 285.75 | 711,847 | 21.97 | 8.63% |
| 1 Month | 229.67 | 295.50 | 208.60 | 251.41 | 638,177 | 46.73 | 20.35% |
| 3 Months | 246.91 | 295.50 | 189.00 | 236.08 | 478,483 | 29.49 | 11.94% |
| 6 Months | 235.27 | 299.98 | 168.2462 | 234.91 | 512,115 | 41.13 | 17.48% |
| 1 Year | 257.78 | 299.98 | 119.7604 | 209.97 | 459,728 | 18.62 | 7.22% |
| 3 Years | 103.86 | 322.67 | 52.33 | 184.81 | 336,037 | 172.54 | 166.13% |
| 5 Years | 101.91 | 322.67 | 52.33 | 164.17 | 267,767 | 174.49 | 171.22% |
Madrigal Pharmaceuticals Description
| Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action. |
